Hepatitis C virus: Screening, diagnosis, and interpretation of laboratory assays

Asian Journal of Transfusion Science

Volumn 8, Issue 1, 2014, Pages 19-25

  Gupta, Ekta ^a   Bajpai, Meenu ^a   Choudhary, Aashish ^a  

^a INSTITUTE OF LIVER AND BILIARY SCIENCES   (India)

Author keywords

Blood borne virus; hepatitis C virus diagnosis; nucleic acid test

Indexed keywords

EID: 84894168629     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.126683     Document Type: Review

References (56)

1. Forman MS, Valsamakis A. Hepatitis C virus. In: Versalovic J, Carrol KC, Funke G, Jorgensen JH, Landry ML, Warrock DW, editors. Murray's Manual of Clinical Microbiology. 10th ed. Washington: American Society of Microbiology Press; 2011. p. 1437-55.
2. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007;13:2436-41.
3. Alter MJ, Seeff LB, Bacon BR, Thomas DL, Rigsby MO, Di Bisceglie AM. Testing for hepatitis C virus infection should be routine for persons at increased risk for infection. Ann Intern Med 2004;141:715-7.
4. Ghany MG, Strader DB, Thomas DL, Seeff LB. American association for the study of liver diseases. Diagnosis, management, and treatment of hepatitis C: An update. Hepatology 2009;49:1335-74.
5. Feinstone SM, Kapikian AZ, Purcell RH, Alter HJ, Holland PV. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N Engl J Med 1975;292:767-70.
6. Lemon SM, Walker C, Alter MJ, Min Kyung Y. Hepatitis C virus. In: Knipe DM, Hpwley PM, editors. Field's Virology. 5th ed. Netherlands: Wolters Kluwer, Philadelphia: Lippincott Williams and Wilkins; 2007. p. 1253-304.
7. Zein NN. Clinical significance of hepatitis C genotypes. Clin Microbiol Rev 2000;13:223-35.
8. Mukhopadhya A. Hepatitis C in India. J Biosci 2008;33:465-73.
9. Nayak NC, Jain D, Vasdev N, Gulwani H, Saigal S, Soin A. Etiologic types of end-stage chronic liver disease in adults: Analysis of prevalence and their temporal changes from a study on native liver explants. Eur J Gastroenterol Hepatol 2012;24:1199-208.
10. Meena M, Jindal T, Hazarika A. Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: A five-year study. Transfusion 2011;51:198-202.
11. Tulsiani S, Choudhury N, Desai P, Shah R, Mathur A, Harimoorthy V, et al. True positivity of anti-Hepatitis C Virus Enzyme-linked immunosorbent assay reactive blood donors: A prospective study done in western India. Asian J Transfus Sci 2012;6:165-8.
12. Choudhury N, Tulsiani S, Desai P, Shah R, Mathur A, Harimoorthy V. Serial follow-up of repeat voluntary blood donors reactive for anti-HCV ELISA. Asian J Transfus Sci 2011;5:26-31.
13. Pallavi P, Ganesh CK, Jayashree K, Manjunath GV. Seroprevalence and trends in transfusion transmitted infections among blood donors in a university hospital blood bank: A 5 year study. Indian J Hematol Blood Transfus 2011;27:1-6.
14. Sood A, Midha V, Bansal M, Sood N, Puri S, Thara A. Perinatal transmission of hepatitis C virus in northern India. Indian J Gastroenterol 2012;31:27-9.
15. Raizada A, Dwivedi S, Bhattacharya S. Hepatitis B, Hepatitis C and HIV co-infection at an antiretroviral centre in Delhi. Trop Doct 2011;41:154-6.
16. Saha K, Firdaus R, Santra P, Pal J, Roy A, Bhattacharya MK, et al. Recent pattern of co-infection amongst HIV sero-positive individuals in a tertiary care hospital, Kolkata. Virol J 2011;8:116.
17. Mahanta J, Borkakoty B, Das HK, Chelleng PK. The risk of HIV and HCV infections among injection drug users in northeast India. AIDS Care 2009;21:1420-4.
18. Jasuja S, Gupta AK, Choudhry R, Kher V, Aggarwal DK, Mishra A, et al. Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol 2009;19:62-7.
19. Jindal N, Jindal M, Jilani N, Kar P. Seroprevalence of hepatitis C virus (HCV) in health care workers of a tertiary care centre in New Delhi. Indian J Med Res 2006;123:179-80.
20. Donahue JG, Muñoz A, Ness PM, Brown DE Jr, Yawn DH, McAllister HA Jr, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992;327:369-73.
21. Thakral B, Marwaha N, Chawla YK, Saluja K, Sharma A, Sharma RR, et al. Prevalence and significance of hepatitis C (HCV) seropositivity in blood donors. Indian J Med Res 2006;124:431-8.
22. Rehan HS, Manak S, Yadav M, Deepinder, Chopra D, Wardhan N. Diversity of genotype and mode of spread of Hepatitis C virus in Northern India. Saudi J Gastroenterol 2011;17:241-4.
23. Chakravarti A, Dogra G, Verma V, Srivastava AP. Distribution pattern of HCV genotypes and its association with viral load. Indian J Med Res 2011;133:326-31.
24. Medhi S, Goswami B, Das AK, Singh TB, Husain SA, Sehgal A, et al. New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India. Arch Virol 2012;157:2083-93.
25. Narahari S, Juwle A, Basak S, Saranath D. Prevalence and geographic distribution of hepatitis C genotypes in Indian patient cohort. Infect Genet Evol 2009;9:643-5.
26. Ponamgi SP, Rahamathulla S, Kumar YN, Chandra M, Lakshmi N, Habibullah CM, et al. Prevalence of hepatitis C virus (HCV) coinfection in HIV inected individuals in south India and characterization of HCV genotypes. Indian J Med Microbiol 2009;27:12-6.
27. Saravanan S, Velu V, Kumarasamy N, Shankar EM, Nandakumar S, Murugavel KG, et al. The prevalence of hepatitis B and hepatitis C virus infection among patients with chronic liver disease in south India. Int J Infect Dis 2008;12:513-8.
28. Chen SL, Morgan TR. The natural history of hepatitis C (HCV) infection. Int J Med Sci 2006;3:47-52.
29. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005;5:558-67.
30. Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: Past, present, and future. J Gastroenterol 2006;41:17-27.
31. Alter MJ, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990;264:2231-5.
32. Blajchman MA, Vamvakas EC. The continuing risk of transfusiontransmitted infections. N Engl J Med 2006;355:1303-5.
33. Lefrere JJ, Guiramand S, Lefrere F, Mariotti M, Aumont P, Lerable J, et al. Full or partial seroreversion in patients infected by hepatitis C virus. J Infect Dis 1997;175:316-22.
34. Barrera JM, Franscis B, Ercilla G, Nelles M, Archod D, Darner J, et al. Improved detection of Anti-HCV in Post transfusion Hepatitis by third generation ELISA. Vox Sang 1995;68:15-8.
35. Morishima C, Gretch DR. Clinical use of Hepatitis C virus test for the diagnosis and monitoring during therapy. Clin Liver Dis 1999;3:717-40.
36. Colin C, Lanoir D, Touzet S, Meyoud-Kraemer L, Bailley F, Trepo C. HEPATITIS Group. Sensitivity and specificity of third-generation hepatitis C virus antibody detection assays: An analysis of the literature. J Viral Hepat 2001;8:87-95.
37. Dow BC, Buchanan I, Munro H, Follet EA, Davidson F, Presscot LE, et al. Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood blood donors. J Med Virol 1996;49:132-6.
38. Recommendations for prevention and control of hepatitis C (HCV) infection and HCV-related chronic disease. Centres for Disease Control and Prevention. MMWR Recomm Rep 1998;47:1-39.
39. Kim S, Kim JH, Yoon S, Park YH, Kim HS. Clinical performance evaluation of four automated chemiluminescence immunoassays for hepatitis C virus antibody detection. J Clin Microbiol 2008;46:3919-23.
40. Ren RF, Lv QS, Zhuang H, Li JJ, Gong XY, Gao GJ, et al. Significance of the signal-to-cutoff ratios of anti-hepatitis C enzyme immunoassays in screening of Chinese blood donors. Transfusion 2005;45:1816-22.
41. Oethinger M, Mayo DR, Falcone J, Barua PK, Griffith BP. Efficiency of the Ortho VITROS Assay for the detection of hepatitis C virusspecific antibodies increased by elimination of supplemental testing of samples with very low sample-to-cutoff ratios. J Clin Microbiol 2005;43:2477-80.
42. Seme K, Poljak M, Babic DZ, Mocilnik T, Vince A. The role of core antigen detection in management of hepatitis C: A critical review. J Clin Virol 2005;32:92-101.
43. Gaudy C, Thevenas C, Tichet J, Mariotte N, Goudeau A, Dubois F. Usefulness of the hepatitis C core antigen assay for screening a population undergoing routine medical checkup. J Clin Chem 2005;43:1722-6.
44. Morota K, Fujinami R, Kinukawa H, Machida T, Ohno K, Saegusa H, et al. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J Virol Methods 2009;157:8-14.
45. Kesli R, Polat H, Terzi Y, Kortoglu MG, Uyar Y. Comparison of a newly developed automated and quantitative hepatitis C virus (HCV) core antigen test with the HCV RNA assay for clinical usefulness in confirming Anti-HCV results. J Clin Microbiol 2011;49:4089-93.
46. Maheshwari A, Ray S, Thuluvath PJ. Acute hepatitis C infection. Lancet 2008;372:321-32.
47. Glenn SA, Wright DJ, Klienman SH, Hirschkorn D, Tu Y, Helderbrant C, et al. Dynamics of viremia in early hepatitis C virus infection. Transfusion 2005;45:994-1002.
48. Kamal SM. Acute hepatitis C: A systematic review. Am J Gastroenterol 2008;103:1283-97.
49. Scott JD, Gretch DR. Molecular diagnostics of hepatitis C virus infection: A systematic review. JAMA 2007;297:724-32.
50. Screening donated blood for transfusion-transmissible infections: Recommendations. World Health Organization; 2009.
51. Panlilo AL, Schaefer MK, Thompson ND. Hepatitis viruses. In: Mayhall CG, editor. Hospital Epidemiology and Infection Control. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2012. p. 662-74.
52. Centers for Disease Control and Prevention (CDC). Recommendations for follow-up of health-care workers after occupational exposure to hepatitis C virus. MMWR Morb Mortal Wkly Rep 1997;46:603-6.
53. Centers for Disease Control and Prevention. Risk of acquiring hepatitis C for health care workers and recommendations for prophylaxis and follow-up after occupational exposure. Hepatitis surveillance Report no 56. Atlanta, Georgia: US. Department of Health and Human Services 1995:3-6.
54. National AIDS Control Organization. An action plan for blood safety. New Delhi: Ministry of Health and Family Welfare, Government of India; 2004:33-7.
55. Strickland GT, El-Kamary SS, Klenerman P, Nicosia A. Hepatitis C vaccine: Supply and demand. Lancet Infect Dis 2008;8:379-86.
56. Yu CI, Chiang BL. A new insight into Hepatitis C vaccine development. J Biomed Biotechnol 2010;2010:548280.